Celox Medical
Company profile
Primary focus
Development, clinical evaluation, and commercialization of patented haemostatic and advanced wound-care technologies.
Why it’s included
The company develops and manufactures chitosan-based hemostatic gauzes and granules, including CELOX Rapid, which is explicitly described as stopping severe bleeding from emergency life-threatening injuries within 60 seconds and is recommended by the US Committee on Tactical Combat Casualty Care, directly matching the topic's requirements for rapid, field-usable hemorrhage control at non-compressible sites.
Relevant capabilities
- Chitosan-based hemostatic material development
- Design and formulation of haemostatic products (granules, gauze, pads)
- Product testing and performance evaluation
- Clinical evaluation and evidence generation
- Advanced wound dressing development
Commercial sectorTopical Hemostatic Agents & Dressings
Technology classesChitosan-based topical hemostatic dressings, Limb tourniquets for extremity hemorrhage control
Relevant commercial products
- CELOX™ Gauze 5’ Z-Fold Gauze
- CELOX Rapid
- CELOX™ Rapid X-Ray Detectable 5’ Z-Fold Gauze – 3in x 5ft (7.6cm x 1.5m)
- CELOXTM
- CELOX Haemostat Device Family